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ABSTRACT
This study investigated 41 infants, aged <4 months, who were hospitalised with symptoms compatible
with pertussis. Of these, 16 had Bordetella pertussis infection conﬁrmed by real-time PCR. For four of
these 16 patients, the initial sample was PCR-negative, but samples collected 5–7 days after the onset of
infection were PCR-positive. PCR was also positive with samples from 15 ⁄ 16 families and 20 ⁄ 41
household contacts. Nine of the 20 positive household contacts were asymptomatic. Among the 16
infants with proven pertussis, apnoea was more frequent than in a control group for whom PCR was
negative with both children and household contacts (69% vs. 28%). It was concluded that real-time PCR
performed with samples from household contacts facilitates the diagnosis of infants suspected clinically
of having pertussis, thereby enabling earlier treatment.
Keywords Apnoea, Bordetella pertussis, household contacts, infants, pertussis, real-time PCR
Original Submission: 31 May 2006; Revised Submission: 12 July 2006; Accepted: 11 August 2006
Clin Microbiol Infect 2007; 13: 172–175
INTRODUCTION
Pertussis is under-diagnosed in adults vaccinated
during infancy in countries where a high vaccine
coverage of infants and children has been
achieved [1,2]. In France, children are ﬁrst vac-
cinated at an age of 2 or 3 months, according to
the vaccination recommendations [3]. A previous
study conducted in the Paris area, which is a
region with a vaccination coverage of >90% in
infancy, showed that 30% of adult patients with a
cough lasting >8 days and without an evident
diagnosis had biological signs of Bordetella per-
tussis infection [4]. Atypical pertussis in adults
contributes to the spread of the disease among
non-immunised infants. The French National
Pertussis network demonstrated that pertussis is
diagnosed mainly in children aged <1 year (80%
of cases), which is the age at which the disease can
be most serious and life-threatening in conjunc-
tion with apnoea [2,5–7]. In France, pertussis is
the most frequent cause of mortality associated
with community-acquired bacterial infection in
children aged <2 months [8].
The present study used a Bordetella-speciﬁc
PCR to systematically screen the household con-
tacts of young infants hospitalised with apnoea or
paroxysmal or vomiting cough during the winter
of 2004–2005, which was a season with known
reported cases of pertussis in Paris. The aim of the
study was to investigate the utility of such a
systematic screen of household contacts in diag-
nosing the disease in children.
PATIENTS AND METHODS
A B. pertussis-speciﬁc real-time PCR (see below) was per-
formed systematically on nasopharyngeal aspirates from all
infants aged <4 months who were hospitalised with apnoea,
with or without a cough, or for a paroxysmal or a vomiting
cough, between 15 October 2004 and 15 March 2005. Apnoea
occurred just before admission, while the onset of cough was
2–5 days previously. Samples from infants were collected
upon admission, and were also collected systematically from
household contacts, i.e., parents, siblings and grandparents, if
they lived in the same dwelling. Household contacts were
questioned concerning the presence, duration and nature of
any cough (particularly during nocturnal sleep). Two groups
of infants were then investigated: (i) infants with a positive
diagnosis of pertussis (a positive PCR sample from the infant
or from one household contact); and (ii) infants with a negative
diagnosis of pertussis (PCR-negative samples from both
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children and household contacts). The children were hospital-
ised in the general paediatric ward of Saint-Vincent de Paul
Hospital, which is a teaching hospital situated in the centre of
Paris. When the Bordetella-speciﬁc PCR was negative or
uninterpretable with samples from an infant, but positive
with samples from a household contact, the PCR was repeated
after 5–7 days with samples from the infant.
Nasopharyngeal aspirates were obtained from young chil-
dren, while a nasopharyngeal sample was collected with a
Dacron swab from adults. Nucleic acids were extracted from
clinical specimens with a QiaAmpDNA bloodminikit (Qiagen,
Hilden, Germany). All samples (200 lL) were extracted accord-
ing to the manufacturer’s instructions. Real-time PCR was
performed as described previously using Hotstar Taq Master
Mix (Qiagen) [9] and primers speciﬁc for a 181-bp region of
IS481 (accession no. L26973). The PCR proﬁle comprised 10 min
at 95C, followed by 50 cycles of 10 s at 95C, 10 s at 55C and
20 s at 72C. Ampliﬁcation, detection and data analysis were
performed with a Light Cycler 2.0 (Roche Diagnostics, Meylan,
France). Negative controls with no template were included in
each PCR run and after every ten samples.
All infants were also screened systematically for respir-
atory syncytial virus (RSV), inﬂuenza virus, parainﬂuenza
virus and adenovirus using standard virological diagnostic
procedures.
RESULTS
Bordetella-speciﬁc PCR was performed with sam-
ples from 41 infants aged <4 months and with
samples from 80 household contacts. The diag-
nosis of pertussis was conﬁrmed by PCR (group
1) for 16 infants (three patients aged <1 month,
ﬁve aged 1–2 months, and eight aged 2–
4 months). For 12 infants, the ﬁrst PCR was
positive; for four other infants, the initial PCR
was negative, but was positive for one of the
household contacts. A second PCR, performed
with samples collected after 5–7 days, was posi-
tive for three of these four patients. The remaining
patient, a boy aged 3 months, yielded a negative
second PCR result, but had typical whooping
cough with paroxysms, and the mother’s PCR
result was positive. Overall, for four of the 16
patients, a positive Bordetella-speciﬁc PCR with
samples from the parents helped to conﬁrm the
diagnosis of pertussis infection in the infants.
Of these 16 infants, 11 had apnoea, alone in
three cases and associated with cough in eight
cases. Five other infants had a paroxysmal cough
with vomiting, with three being hospitalised for
RSV bronchiolitis. Among the 11 infants with
apnoea, eight were admitted to the paediatric
intensive care unit (PICU). Overall, six of 16
infants were co-infected with RSV. No other viral
infections were detected.
In 15 of 16 families of the positive infants, at
least one household contact had a positive Borde-
tella-speciﬁc PCR result. In one family, only the
mother was tested and she was negative. Overall,
20 (48.8%) household contacts yielded a positive
Bordetella-speciﬁc PCR result. The positive house-
hold contacts comprised nine (56.2%) of 16
mothers, four of ten fathers (six were not tested),
ﬁve (45.4%) of 11 siblings, and one of four
grandparents. In seven of the 16 cases, the infant
was the ﬁrst child and was living with his parents
only. Of the 20 household contacts positive for
B. pertussis, only ten had a cough lasting for
>5 days, with waking during nocturnal sleep in
four cases. Among the other household contacts,
four did not cough, and ﬁve had a mild cough
lasting <5 days, which was considered to be
common during the winter season (Table 1).
All the parents and siblings living with the
infants had received a whole-cell pertussis vac-
cine during childhood. This information was not
available for the four grandparents living in the
household. No sibling aged <6 years was PCR-
positive, and two brothers (aged 7 and 8 years)
who were PCR-positive did not have a cough.
Patients and household contacts positive for
B. pertussis received treatment with macrolides
(clarythromycin or azithromycin). In the infants,
apnoeas eased within 2–4 days of commencing
treatment, but the cough took longer to disappear.
Two of these 16 infants had received a single dose
of acellular pertussis vaccine. The others had not
received any vaccine.
During the same period, 26 other infants aged
<4 months were hospitalised with symptoms
resembling pertussis, i.e., apnoea in seven
(28%) cases (alone in two cases and apnoea with
cough in ﬁve cases), or vomiting cough (18
cases), with four of these 18 cases having a
cough with paroxysms on the day of admission.
All of these infants were negative when tested
using the Bordetella-speciﬁc real-time PCR (group
2). The real-time PCR was also performed with
specimens from 39 household contacts, including
23 mothers and 16 fathers, but was negative on
every occasion. The apnoea and ⁄ or cough were
probably related in most cases to gastro-oeso-
phageal reﬂux or viral infection; indeed, 13 in-
fants were infected with RSV. Five of these 26
infants were admitted to the PICU. The four
infants who had paroxysmal cough were all
Raymond et al. Pertussis in young infants 173
 2006 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 13, 172–175
positive for RSV, and the paroxysms stopped 24–
48 h after admission.
Overall, during the winter season investigated,
six infants aged <4 months with RSV-positive
bronchiolitis were admitted to the PICU. Of these,
three had a positive Bordetella-speciﬁc PCR result
in association with the viral infection. No other
viral infections were detected.
DISCUSSION
Pertussis is under-diagnosed in countries with
high vaccine coverage, often because the symp-
toms are atypical, especially in teenagers and
adults vaccinated during their childhood [10,11].
Severe morbidity and mortality are greatest
among infants, particularly those who are either
not immunised or not completely immunised. In
the USA, it has been estimated that >70% of
deaths caused by pertussis were not properly
reported in 1994–1995 [6]. Teenagers and adults
vaccinated during childhood contribute to the
spread of the disease, and are a reservoir of infec-
tion for very young infants, in whom pertussis
may be severe and life-threatening [1,2,10,11].
Recommendations for booster immunisations of
teenagers in the USA [10,11] and in young parents
(before the birth for fathers, and just after the birth
for mothers) in France [3] are not generally
followed.
Diagnosis of pertussis relies mainly on clinical
symptoms, as bacterial cultures are often negat-
ive. Serological testing can help to diagnose
atypical pertussis, but does not provide timely
results because of the necessity to compare two
successive sera [1]. Real-time PCR for Bordetella
allows a quick diagnosis, but may be unreliable
because of low bacterial numbers in the rhino-
pharynx, particularly at the beginning of the
disease. In the present study, the Bordetella-speciﬁc
PCR was initially negative or uninterpretable in
four of 16 cases, but was positive with a second
specimen in three cases. The infants were in the
ﬁrst phase of the disease, and only ﬁve of 16 had
whooping cough with paroxysms; however, the
same symptomswere also present upon admission
for some infants with RSV-positive bronchiolitis
who yielded a negative Bordetella-speciﬁc PCR.
The present study demonstrated that testing of
household contacts is useful in conﬁrming a
diagnosis of pertussis in infants, even if the
parents do not have speciﬁc symptoms. Indeed,
among the 20 household contacts of the children
positive for B. pertussis, only one had the typical
symptoms of pertussis, although ten had been
coughing for >5 days. The remainder had been
coughing for <5 days, or not at all in four cases.
These results suggest that transmission of B. per-
tussis can occur via asymptomatic adult carriers in
close contact with incompletely vaccinated young
infants. Of the 16 children with pertussis, 14 were
non-vaccinated and two had received only one
dose, which is not sufﬁcient to protect against
pertussis.
The 41 infants tested for pertussis had iden-
tical symptoms, but the 16 infants with a positive
Bordetella-speciﬁc PCR presented more often with
apnoea (69% vs. 28%). These observations
should be conﬁrmed in larger studies. The 25
infants with a negative Bordetella-speciﬁc PCR
could not be differentiated clinically from the 16
positive cases upon admission, but the house-
hold contacts of these 25 infants were all
PCR-negative. These results suggest that a Borde-
tella-speciﬁc PCR should be performed system-
atically on household contacts following
admission of an infant, even in the absence of
speciﬁc symptoms, to help to conﬁrm a possible
diagnosis of pertussis in the infant. It is import-
ant to note that viral infections do not exclude an
association with pertussis; thus, three of six
infants presenting with RSV-positive bronchioli-
tis and admitted to the PICU had an associated
pertussis infection [7].
Table 1. Results of real-time Bordetella-speciﬁc PCR for 41






Index case (n = 41) 15 + 1a 0 ⁄ 25
Apnoea
Total 11 (68.7%)b 7 (28%)
Apnoea alone 3 2
Apnoea + cough 8 5
Paroxysmal or vomiting cough 5 18
RSV-positive 6 (37%) 13 (52%)
Household contacts
Household members
Total 20 ⁄ 41 (48.8%) 0 ⁄ 39
Mothers 9 ⁄ 16 (56.2%) 0 ⁄ 23
Fathers 4 ⁄ 10 (25%) 0 ⁄ 16
Siblings 5 ⁄ 11 (45.4%)
Grandparents 1 ⁄ 4
No cough (or cough <5 days) 9 24
Cough >5 days 10 15
Paroxysmal or vomiting cough 1 0
aTypical whooping cough with PCR-negative result, but PCR-positive household
contact.
bp <0.01.
RSV, respiratory syncytial virus.
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It is accepted widely that early antibiotic
treatment reduces clinical symptoms, and conse-
quently may reduce the mortality and the length
of hospitalisation [2]. In young infants with a
pertussis infection at its early stage, antibiotic
treatment can diminish the severity of symptoms
and the complications [12]. In the USA, 56 of 62
children who died of pertussis infection at the end
of the 1990s were aged <6 months [2,6], and a
recent French study showed that pertussis was
the most important cause of mortality associated
with community-acquired bacterial infection be-
fore the age of 2 months [8]. Therefore, diagnosis
should be made as quickly as possible in young
infants, especially in cases of apnoea, to enable the
initiation of antibiotic treatment. Testing house-
hold contacts may allow the detection of intra-
familial infection, leading to an earlier diagnosis
of pertussis in young infants, and making the
additional expense of PCR cost-effective [7].
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